Deep dive into achieving the therapeutic target: results from a prospective, 6‑month, observational study nested in routine rheumatoid arthritis care.

Introduction: Achieving remission or lowdisease activity (LDA) is an integral principle of treat‑to‑target (T2T) strategy in rheumatoid arthritis (RA). Prior studies have reported that achieving T2T therapeutic goals may be realistic only for a fraction of patients. Prospective, real‑world data on achieving target disease control in ambulatory care populations are limited for Central and Eastern European countries.

Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care.

Introduction: Real-world data indicate disparities in biologic access across Europe.

Objectives: To describe the national structure of PsA care in Poland, with a particular focus on the population of inadequate responders (IRs) and difficulties associated with biologic therapy access.

Methods: A pool of rheumatologic and dermatologic care centers was created based on National Health Fund contract lists ( = 841), from which 29 rheumatologic and 10 dermatologic centers were sampled randomly and successfully met the inclusion criterium.

Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis.

Introduction: Difficult-to-treat rheumatoid arthritis (RA) is a significant clinical problem despite no clear definition. We aimed to provide clinical characteristics and associated comorbidities of RA patients in relation to disease control.

Methods: RA characteristics and physician-recorded comorbidities were analyzed in a sample of 1937 RA patients.

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study.

Introduction: There are no reliable data regarding the prevalence of rheumatoid arthritis (RA) in Poland.

Material And Methods: The first stage was a face-to-face survey on a nationwide representative sample of 3000 people, which identified respondents with a physician-confirmed diagnosis of RA. The second stage was a survey of RA patients, which characterized the disease course and treatment.